IXICO jumps as broker hails ‘pivotal year’ and sharp forecast upgrades
IXICO PLC (LSE:IXI, OTC:PHYOF) shares climbed on Tuesday after Cavendish said the neuroscience imaging specialist had delivered a “pivotal year”, prompting...…
0,140€
12,90%
Echtzeit-Aktienkurs IXICO PLC
Bid:
Ask:
Nachrichten zur IXICO PLC Aktie
IXICO shares rise 4% as company gives an upbeat assessment of prospects
IXICO PLC (LSE:IXI, OTC:PHYOF) shares jumped 4% to 11.13p after the company said it is entering 2026 with strong momentum, helped…
IXICO upbeat on 2026 as contract wins swell order book
IXICO PLC (LSE:IXI, OTC:PHYOF) has struck an optimistic tone for the year ahead after a surge in new business pushed its…
IXICO tipped to keep growing, broker eyes upcoming catalysts
Cavendish has reiterated its positive stance on IXICO PLC (LSE:IXI, OTC:PHYOF) as the company targets growth in Alzheimer’s and Parkinson’s…
IXICO adds two leading dementia specialists to advisory board
IXICO PLC (LSE:IXI, OTC:PHYOF), the London-based neuroscience imaging group, has brought two of the world’s best-known dementia researchers on to…
IXICO signs £3.5m Huntingtons trial contract
IXICO PLC (LSE:IXI, OTC:PHYOF) CEO, Bram Goorden, talked with Proactive about the companys latest progress in neuroimaging and clinical trial analytics....…
IXICO signs £3.5m Huntingtons trial contract
IXICO PLC (LSE:IXI, OTC:PHYOF) CEO, Bram Goorden, talked with Proactive about the companys latest progress in neuroimaging and clinical trial analytics....…
IXICO climbs 5% on £3.5 million Huntington’s trial win
IXICO PLC (LSE:IXI, OTC:PHYOF) shares jumped 5% to 11.28p after the neuroscience analytics specialist landed a four-year contract worth more than…
IXICO lands £3.5 million contract for global Huntington’s trial
IXICO PLC (LSE:IXI, OTC:PHYOF) has secured a contract worth more than £3.5 million to support a major phase III clinical trial…
IXICO lands £3.5m contract for global Huntington’s trial
IXICO PLC (LSE:IXI, OTC:PHYOF) has secured a contract worth more than £3.5 million to support a major phase III clinical trial…
IXICO CEO on biomarker strategy and growth
IXICO PLC (LSE:IXI, OTC:PHYOF) CEO, Bram Goorden, talked with Proactive about the company’s strong performance in 2025, highlighting above-guidance revenue...…
IXICO shares rise 4% on stronger-than-expected revenue growth
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF) climbed 4% to 13p after the neuroscience data firm reported a 13% rise in annual…
IXICO: Blood test deal gives small-cap a shot in the arm
A pair of new contracts has given a lift to IXICO PLC (LSE:IXI, OTC:PHYOF), the London-listed neuroscience data specialist whose…
IXICO strikes key data deal with Alzheimer’s research group to bolster biomarker capabilities
IXICO PLC (LSE:IXI, OTC:PHYOF), the London-based brain imaging company, has expanded its partnership with the Global Alzheimer’s Platform Foundation (GAP)...…
IXICO shares jump as much as 15% as full-year revenues set to beat forecasts
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF) rose as much as 15% on Thursday after the neuroscience analytics group said it expects…
IXICO expects 2025 revenues to exceed forecasts as strategy starts to bear fruit
IXICO PLC (LSE:IXI, OTC:PHYOF) said on Thursday that it expects full-year revenues to come in ahead of expectations, marking a…
IXICO shares jump 9% after playing key role in FDA-approved Alzheimer’s blood test
Shares in IXICO PLC (LSE:IXI, OTC:PHYOF) rose 9% after the neuro-imaging specialist confirmed its involvement in the first FDA-approved blood test…
IXICO supports first US approval of blood test for Alzheimer’s diagnosis
IXICO PLC (LSE:IXI, OTC:PHYOF), the neuro-imaging specialist, played a key role in the US approval of a new blood test…
IXICO shares jump as company signals it may exceed expectations for the year
Shares in neuroscience analytics firm IXICO PLC (LSE:IXI, OTC:PHYOF) rose 11% on Tuesday after the company said it was well…
IXICO says focused strategy has put it on course to exceed full-year expectations
IXICO PLC (LSE:IXI, OTC:PHYOF) said on Tuesday it is on track to meet or exceed expectations for the year, crediting a…
IXICO shares boosted by upbeat trading update
IXICO PLC (AIM:IXI, OTC:PHYOF) told investors it expects to report £3.2 million of revenue for the six months to 31…
IXICO offers significant upside now it has strengthened its balance sheet
With a stronger balance sheet secured, Cavendish believes IXICO PLC (AIM:IXI, OTC:PHYOF) shares offer significant upside for investors. The med-tech firm,...…
IXICO lands £500k phase II Huntingtons contract
IXICO PLC (AIM:IXI, OTC:PHYOF), a neuroscience imaging company, has secured a new contract with a US-based client for a phase…
IXICO up 33% after £5.8m order boost
IXICO PLC (AIM:IXI, OTC:PHYOF) shares surged 33% following a positive trading update in which it said it had landed new contract…